Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Free Subscription

Articles published in Emerg Infect Dis

Retrieve available abstracts of 80 articles:
HTML format

Single Articles

    May 2020
  1. BAIK Y, Modongo C, Moonan PK, Click ES, et al
    Possible Transmission Mechanisms of Mixed Mycobacterium tuberculosis Infection in High HIV Prevalence Country, Botswana.
    Emerg Infect Dis. 2020;26:953-960.
    PubMed     Abstract available

  2. RATHI P, Shringarpure K, Unnikrishnan B, Chadha VK, et al
    Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017.
    Emerg Infect Dis. 2020;26:989-992.
    PubMed     Abstract available

  3. HORTON KC, Hoey AL, Beraud G, Corbett EL, et al
    Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and Control.
    Emerg Infect Dis. 2020;26:910-919.
    PubMed     Abstract available

  4. MOONAN PK, Zetola NM, Tobias JL, Basotli J, et al
    A Neighbor-Based Approach to Identify Tuberculosis Exposure, the Kopanyo Study.
    Emerg Infect Dis. 2020;26:1010-1013.
    PubMed     Abstract available

    April 2020
  5. VAN DEN BOOGAARD J, Slump E, Schimmel HJ, van der Hoek W, et al
    High Incidence of Active Tuberculosis in Asylum Seekers from Eritrea and Somalia in the First 5 Years after Arrival in the Netherlands.
    Emerg Infect Dis. 2020;26:675-681.
    PubMed     Abstract available

    March 2020
  6. CAMPBELL JR, Falzon D, Mirzayev F, Jaramillo E, et al
    Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available

  7. GETAHUN M, Blumberg HM, Sinshaw W, Diriba G, et al
    Low Prevalence of Mycobacterium bovis in Tuberculosis Patients, Ethiopia.
    Emerg Infect Dis. 2020;26:613-615.
    PubMed     Abstract available

  8. ZHANG G, Zhang Y, Zhong D, Meng S, et al
    High Prevalence of and Risk Factors for Latent Tuberculosis Infection among Prisoners, Tianjin, China.
    Emerg Infect Dis. 2020;26:516-522.
    PubMed     Abstract available

  9. MERKER M, Nikolaevskaya E, Kohl TA, Molina-Moya B, et al
    Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Emerg Infect Dis. 2020;26:481-490.
    PubMed     Abstract available

  10. TSANG CA, Langer AJ, Kammerer JS, Navin TR, et al
    US Tuberculosis Rates among Persons Born Outside the United States Compared with Rates in Their Countries of Birth, 2012-2016(1).
    Emerg Infect Dis. 2020;26:533-540.
    PubMed     Abstract available

  11. TIBBETTS KK, Ottoson RA, Tsukayama DT
    Public Health Response to Tuberculosis Outbreak among Persons Experiencing Homelessness, Minneapolis, Minnesota, USA, 2017-2018.
    Emerg Infect Dis. 2020;26:420-426.
    PubMed     Abstract available

  12. HUANG CC, Chu AL, Becerra MC, Galea JT, et al
    Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru.
    Emerg Infect Dis. 2020;26:568-578.
    PubMed     Abstract available

  13. SHUAIB YA, Khalil EAG, Wieler LH, Schaible UE, et al
    Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan(1).
    Emerg Infect Dis. 2020;26:427-436.
    PubMed     Abstract available

    November 2019
  14. BAFFOE-BONNIE A, Houpt ER, Turner L, Dodge D, et al
    Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available

  15. FELLAG M, Saad J, Armstrong N, Chabriere E, et al
    Routine Culture-Resistant Mycobacterium tuberculosis Rescue and Shell-Vial Assay, France.
    Emerg Infect Dis. 2019;25:2131-2133.
    PubMed     Abstract available

    October 2019
  16. SAKHAEE F, Vaziri F, Bahramali G, Taremian K, et al
    Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran.
    Emerg Infect Dis. 2019;25:1984-1986.
    PubMed     Abstract available

  17. VONNAHME LA, Haddad MB, Navin TR
    Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011-2012.
    Emerg Infect Dis. 2019;25:1949-1951.
    PubMed     Abstract available

  18. MURRAY KO, Castillo-Carandang NT, Mandalakas AM, Cruz AT, et al
    Prevalence of Tuberculosis in Children After Natural Disasters, Bohol, Philippines.
    Emerg Infect Dis. 2019;25:1884-1892.
    PubMed     Abstract available

    September 2019
  19. KUMAR A, Kunoor A, Eapen M, Singh PK, et al
    Blastomycosis Misdiagnosed as Tuberculosis, India.
    Emerg Infect Dis. 2019;25:1776-1777.
    PubMed     Abstract available

  20. SINGH PK, Jain A
    Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone.
    Emerg Infect Dis. 2019;25:1760-1762.
    PubMed     Abstract available

    July 2019
  21. HUANG F, van den Hof S, Qu Y, Li Y, et al
    Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis, China.
    Emerg Infect Dis. 2019;25:1289-1296.
    PubMed     Abstract available

  22. BRODE SK, Chung H, Campitelli MA, Kwong JC, et al
    Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available

  23. HIGGITT RL, Louis van Schalkwyk O, de Klerk-Lorist LM, Buss PE, et al
    Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa.
    Emerg Infect Dis. 2019;25:1425-1427.
    PubMed     Abstract available

    May 2019
  24. MBUAGBAW L, Guglielmetti L, Hewison C, Bakare N, et al
    Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:936-943.
    PubMed     Abstract available

  25. PAUDEL S, Nakajima C, Mikota SK, Gairhe KP, et al
    Mixed Mycobacterium tuberculosis Lineage Infection in 2 Elephants, Nepal.
    Emerg Infect Dis. 2019;25:1031-1032.
    PubMed     Abstract available

  26. LUIS BAL, Diaz-Lomeli P, Gomez-Albarran LP, Martinez-Gamboa A, et al
    Mycobacterium obuense Bacteremia in a Patient with Pneumonia.
    Emerg Infect Dis. 2019;25:1015-1016.
    PubMed     Abstract available

    April 2019
  27. CAMPBELL JR, Johnston JC, Cook VJ, Sadatsafavi M, et al
    Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Emerg Infect Dis. 2019;25:661-671.
    PubMed     Abstract available

    March 2019
  28. HOLLAND DP, Alexander S, Onwubiko U, Goswami ND, et al
    Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017.
    Emerg Infect Dis. 2019;25:593-595.
    PubMed     Abstract available

  29. LOVEDAY M, Hlangu S, Furin J
    Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:609-610.
    PubMed     Abstract available

  30. GENESTET C, Tatai C, Berland JL, Claude JB, et al
    Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018.
    Emerg Infect Dis. 2019;25:589-592.
    PubMed     Abstract available

  31. SKIBA Y, Mokrousov I, Nabirova D, Vyazovaya A, et al
    Mycobacterium tuberculosis RD-Rio Strain in Kazakhstan.
    Emerg Infect Dis. 2019;25:604-606.
    PubMed     Abstract available

  32. WANSAULA Z, Wortham JM, Mindra G, Haddad MB, et al
    Bacillus Calmette-Guerin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015.
    Emerg Infect Dis. 2019;25:451-456.
    PubMed     Abstract available

  33. PANG Y, An J, Shu W, Huo F, et al
    Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008-2017.
    Emerg Infect Dis. 2019;25:457-464.
    PubMed     Abstract available

  34. OSMAN M, Harausz EP, Garcia-Prats AJ, Schaaf HS, et al
    Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:441-450.
    PubMed     Abstract available

  35. CRUZ AT, Starke JR
    Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017.
    Emerg Infect Dis. 2019;25:523-528.
    PubMed     Abstract available

  36. BAINOMUGISA A, Pandey S, Donnan E, Simpson G, et al
    Cross-Border Movement of Highly Drug-Resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010-2015.
    Emerg Infect Dis. 2019;25:406-415.
    PubMed     Abstract available

  37. DOMINGUEZ J, Acosta F, Perez-Lago L, Sambrano D, et al
    Simplified Model to Survey Tuberculosis Transmission in Countries Without Systematic Molecular Epidemiology Programs.
    Emerg Infect Dis. 2019;25:507-514.
    PubMed     Abstract available

  38. ARANDJELOVIC I, Merker M, Richter E, Kohl TA, et al
    Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, Serbia.
    Emerg Infect Dis. 2019;25:555-558.
    PubMed     Abstract available

  39. BOUZOUITA I, Cabibbe AM, Trovato A, Daroui H, et al
    Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.
    Emerg Infect Dis. 2019;25:538-546.
    PubMed     Abstract available

  40. LIPWORTH S, Jajou R, de Neeling A, Bradley P, et al
    SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex.
    Emerg Infect Dis. 2019;25:482-488.
    PubMed     Abstract available

  41. EL ACHKAR S, Demanche C, Osman M, Rafei R, et al
    Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.
    Emerg Infect Dis. 2019;25:564-568.
    PubMed     Abstract available

  42. ACOSTA F, Agapito J, Cabibbe AM, Caceres T, et al
    Exportation of MDR TB to Europe from Setting with Actively Transmitted Persistent Strains in Peru.
    Emerg Infect Dis. 2019;25:596-598.
    PubMed     Abstract available

    December 2018
  43. MILLER MA, Buss P, Parsons SDC, Roos E, et al
    Conservation of White Rhinoceroses Threatened by Bovine Tuberculosis, South Africa, 2016-2017.
    Emerg Infect Dis. 2018;24:2373-2375.
    PubMed     Abstract available

  44. SANTOS N, Nunes T, Fonseca C, Vieira-Pinto M, et al
    Spatial Analysis of Wildlife Tuberculosis Based on a Serologic Survey Using Dried Blood Spots, Portugal.
    Emerg Infect Dis. 2018;24:2169-2175.
    PubMed     Abstract available

    November 2018
  45. KAYOMO MK, Hasker E, Aloni M, Nkuku L, et al
    Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo.
    Emerg Infect Dis. 2018;24:2029-2035.
    PubMed     Abstract available

  46. NISHIMURA T, Ota M, Mori M, Hasegawa N, et al
    Estimating Latent Tuberculosis Infection Using Interferon-gamma Release Assay, Japan.
    Emerg Infect Dis. 2018;24:2111-2113.
    PubMed     Abstract available

  47. AUNG HL, Nyunt WW, Fong Y, Russell B, et al
    Acquired Resistance to Antituberculosis Drugs.
    Emerg Infect Dis. 2018;24:2134.

    October 2018
  48. HADDAD MB, Raz KM, Lash TL, Hill AN, et al
    Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011-2015.
    Emerg Infect Dis. 2018;24:1930-1933.
    PubMed     Abstract available

  49. GARFEIN RS, Liu L, Cuevas-Mota J, Collins K, et al
    Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA.
    Emerg Infect Dis. 2018;24:1806-1815.
    PubMed     Abstract available

    June 2018
  50. MICHELET L, De Cruz K, Henault S, Tambosco J, et al
    Mycobacterium bovis Infection of Red Fox, France.
    Emerg Infect Dis. 2018;24:1150-1153.
    PubMed     Abstract available

  51. SANTIN M, Barrabeig I, Malchair P, Gonzalez-Luquero L, et al
    Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014.
    Emerg Infect Dis. 2018;24:1091-1094.
    PubMed     Abstract available

    March 2018
  52. NGUYEN DT, Teeter LD, Graves J, Graviss EA, et al
    Characteristics Associated with Negative Interferon-gamma Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015.
    Emerg Infect Dis. 2018;24:534-540.
    PubMed     Abstract available

  53. CHERNYAEVA E, Rotkevich M, Krasheninnikova K, Yurchenko A, et al
    Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
    Emerg Infect Dis. 2018;24:579-583.
    PubMed     Abstract available

  54. ALTHOMSONS SP, Hill AN, Harrist AV, France AM, et al
    Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
    Emerg Infect Dis. 2018;24:573-575.
    PubMed     Abstract available

  55. RANDO-SEGURA A, Aznar ML, Moreno MM, Espasa M, et al
    Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Emerg Infect Dis. 2018;24:569-572.
    PubMed     Abstract available

  56. BRENT AJ, Nyundo C, Langat J, Mulunda C, et al
    Prospective Observational Study of Incidence and Preventable Burden of Childhood Tuberculosis, Kenya.
    Emerg Infect Dis. 2018;24:514-523.

  57. NAIK PR, Moonan PK, Nirgude AS, Shewade HD, et al
    Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.
    Emerg Infect Dis. 2018;24:478-484.
    PubMed     Abstract available

  58. YEN YF, Pan SW, Su VY, Chuang PH, et al
    Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan(1).
    Emerg Infect Dis. 2018;24:498-505.
    PubMed     Abstract available

  59. KLOTZ D, Barth SA, Baumgartner W, Hewicker-Trautwein M, et al
    Mycobacterium avium subsp. hominissuis Infection in a Domestic Rabbit, Germany.
    Emerg Infect Dis. 2018;24:596-598.
    PubMed     Abstract available

  60. LOUTET MG, Davidson JA, Brown T, Dedicoat M, et al
    Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
    Emerg Infect Dis. 2018;24:524-533.
    PubMed     Abstract available

    November 2017
  61. NATHAVITHARANA RR, Shi CX, Chindelevitch L, Calderon R, et al
    Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.
    Emerg Infect Dis. 2017;23:1887-1890.
    PubMed     Abstract available

  62. TAO NN, He XC, Zhang XX, Liu Y, et al
    Drug-Resistant Tuberculosis among Children, China, 2006-2015.
    Emerg Infect Dis. 2017;23:1800-1805.
    PubMed     Abstract available

    October 2017
  63. ACHAR J, Hewison C, Cavalheiro AP, Skrahina A, et al
    Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available

  64. MARYANDYSHEV A, Pontali E, Tiberi S, Akkerman O, et al
    Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available

  65. JASPARD M, Elefant-Amoura E, Melonio I, De Montgolfier I, et al
    Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available

    March 2017
  66. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    Mycobacterium tuberculosis Transmission among Elderly Persons, Yamagata Prefecture, Japan, 2009-2015.
    Emerg Infect Dis. 2017;23:448-455.
    PubMed     Abstract available

  67. MALM S, Linguissi LS, Tekwu EM, Vouvoungui JC, et al
    New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, Congo.
    Emerg Infect Dis. 2017;23:423-429.
    PubMed     Abstract available

  68. ADJEMIAN J, Frankland TB, Daida YG, Honda JR, et al
    Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.
    Emerg Infect Dis. 2017;23:439-447.
    PubMed     Abstract available

  69. SCOTT C, Cavanaugh JS, Silk BJ, Ershova J, et al
    Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.
    Emerg Infect Dis. 2017;23:456-462.
    PubMed     Abstract available

  70. BOURDILLON PM, Goncalves CC, Pelissari DM, Arakaki-Sanchez D, et al
    Increase in Tuberculosis Cases among Prisoners, Brazil, 2009-20141.
    Emerg Infect Dis. 2017;23:496-499.
    PubMed     Abstract available

  71. SIMPSON G, Zimmerman R, Shashkina E, Chen L, et al
    Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.
    Emerg Infect Dis. 2017;23:513-516.
    PubMed     Abstract available

  72. CHANDRANAIK BM, Shivashankar BP, Umashankar KS, Nandini P, et al
    Mycobacterium tuberculosis Infection in Free-Roaming Wild Asian Elephant.
    Emerg Infect Dis. 2017;23:555-557.
    PubMed     Abstract available

  73. BENOIT SR, Gregg EW, Jonnalagadda S, Phares CR, et al
    Association of Diabetes and Tuberculosis Disease among US-Bound Adult Refugees, 2009-2014.
    Emerg Infect Dis. 2017;23:543-545.
    PubMed     Abstract available

  74. ALLANA S, Shashkina E, Mathema B, Bablishvili N, et al
    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
    Emerg Infect Dis. 2017;23:491-495.
    PubMed     Abstract available

  75. ZACHARIAH A, Pandiyan J, Madhavilatha GK, Mundayoor S, et al
    Mycobacterium tuberculosis in Wild Asian Elephants, Southern India.
    Emerg Infect Dis. 2017;23:504-506.
    PubMed     Abstract available

  76. MILLER MA, Buss PE, van Helden PD, Parsons SD, et al
    Mycobacterium bovis in a Free-Ranging Black Rhinoceros, Kruger National Park, South Africa, 2016.
    Emerg Infect Dis. 2017;23:557-558.
    PubMed     Abstract available

  77. DAVIDSON JA, Loutet MG, O'Connor C, Kearns C, et al
    Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
    Emerg Infect Dis. 2017;23:377-386.
    PubMed     Abstract available

  78. SURIE D, Fane O, Finlay A, Ogopotse M, et al
    Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.
    Emerg Infect Dis. 2017;23:487-490.
    PubMed     Abstract available

    February 2017
  79. DENNING DW, Perlin DS, Muldoon EG, Colombo AL, et al
    Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available

    December 2016
  80. BARASONA JA, Acevedo P, Diez-Delgado I, Queiros J, et al
    Tuberculosis-Associated Death among Adult Wild Boars, Spain, 2009-2014.
    Emerg Infect Dis. 2016;22:2178-2180.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.